The year was 1962, and Lester T. Jones (Fig. 1) .
The procedure of bypassing the upper lacrimal system by insertion of a Jones tube has become the standard of care. 1 Countless patients have been helped by this surgery, conjunctivodacryocystorhinostomy (CDCR) with Jones tube placement. The tube is well tolerated and remains removable for yearly debriding of mucus and the occasional need to alter the collar size or length (to hang in soft tissue suspension unobstructed mid way from the lateral wall of the nose to the nasal septum). However, for some patients, the tube is a little too free and becomes dislodged during a sneeze or cough, or even during sleep. Extrusion rates as high as 49% have been reported. 2 We describe the use of a new tube that retains the advantages of the traditional smooth Pyrex tube, yet appears to improve the positional stability in the surgically created fistula.
METHODS
Patients who had previously undergone CDCR from an external approach of a single surgeon who later had extrusion of their Pyrex Jones tubes were placed in a case series. Ten patients were followed. All had previous success with Pyrex Jones tubes, with follow-up ranging from 1 month to 14 years. All presented with a tube that had "fallen out" and requested replacement. The Frosted Pyrex Jones tube (Weiss Scientific Glass Blowing Company, Portland, OR, U.S.A.) was used as the replacement.
After undergoing primary CDCR, each patient is instructed to make an office visit as soon as possible if the Jones tube became dislodged. Then, in the examination room, the patient is placed in a seated position. Topical anesthesia is administered by one drop (proparacaine eye drops; proparacaine hydrochloride ophthalmic solution 0.5%, Bausch & Lomb Pharmaceuticals, Inc., Tampa, FL, U.S.A.). The conjunctival/nasal mucosa fistula tract is probed and dilated with a Jones gold dilator. Further topical anesthesia is given as necessary. The dilator is removed, and a frosted Jones tube inserted in the fistula tract over a Bowman probe that is subsequently removed. Proper fitting includes a collar of reasonable diameter to sit well without migrating in the tract and sufficient length to have the end of the tube suspended between the lateral wall of the nose and the nasal septum as viewed up the nostril with a speculum. 3 The insertion of the frosted Jones tube is no different than that of the traditional smooth Jones tube. Similarly, the removal for fitting and/or cleaning is identical. The frosted Jones tube preserves the ease of manual removal for the clinician while providing some friction to reduce the incidence of spontaneous extrusion (Figs. 2 and 3, A, B) .
RESULTS
We have successfully treated 10 patients with frosted Jones tubes over the last 8 months. We find that insertion is the same as with the smooth tubes, and extraction for fitting proper lengths is not complicated by the frosting. Of the 10 patients with the frosted Jones Pyrex tubes, none have had a recurrence of spontaneous extrusion. All have reported proper functioning of the tubes, with no complaints of epiphora or discomfort. As a preliminary study, our follow-up is currently limited to 8 months. 
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Conjunctivodacryocystorhinostomy with the insertion of a Jones tube remains the standard of care for canalicular obstruction. Various means of performing a CDCR have been adequately described in the literature. 4 -7 Although a vast majority of patients are satisfied by obtaining a dry, comfortable eye, extrusion remains the chief long-term complication, 2 with extrusion rates as high as 18% to 49%. 2, 8 Through collaboration with the original inventor, Mr. Gunther Weiss, we have found that the addition of the frosted coating to the outer surface retains all the benefits of the original tube with the added improvement of a decrease in extrusion rates. The capillary action is preserved by both the internal diameter and material of the Pyrex glass. The inert material remains well accepted by the body. And, most importantly, the frosted coating fixes the tube more securely in place (by simple friction) while still allowing easy manual removal for fittings and cleanings. Fibrovascular ingrowth in the coating does not appear to be necessary to obtain positional stability.
DISCUSSION
We recognize the short duration of the follow-up period in this study. We look forward to providing additional evidence in the future regarding long-term success of this new tube. 
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